Loading...

ENG KOR

KB STAR ETF 로고

홈으로 이동

KOR ENG

ETF Finder

Home Product Lineup ETF Finder Product Details
Domestic
Equity Passive

RISE Healthcare (253280)

Update : 2026.06.19

NAV

13,677KRW

-415.63하락 (-2.95%)

Market Price per share (KRW)

13,705KRW

-415하락 (-2.94%)

※ t-1 last price

trading volume

3,804shares

AUM

KRW 8.8billion

Share it

RISE Healthcare (253280)

Overview Performance Holdings

KEY POINT

Invest in domestic healthcare companies (medical equipment and services, bio, pharmaceutical)

KEY POINT

Invest in selected healthcare companies based on financial conditions among the top 500 companies by market capitalization of the KOSPI and KOSDAQ markets

Basic information

Download trading information

Update : 2026.06.19
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare ETF
(253280) 		FnGuide HealthCare Index 2016.09.23 50,000 8,890,144,612
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 13,705
※ t-1 last price 		13,677 3,804
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%) Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare ETF

(253280) 		FnGuide HealthCare Index
Inception date Creation Unit
2016.09.23 50,000
AUM(0.1 billion) (KRW) Trustee
8,890,144,612 하나은행
Market Price per share (KRW) iNAV per share (KRW)
13,705
※ t-1 last price 		13,677
Trading Volume (shares)
3,804
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%)
Distribution Frequency
Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Index is a market capitalization weighted index. The index selects stocks that satisfy financial and management soundness criteria out of the universe of stocks come under the medical sector in the MKF 500.

View detailed index information

TOP 10 Holdings

Update : 2026-06-19
Rank , Name, proportion table
Rank Name Weight (%)
1 SAMSUNG BIOLOGICS 10.55
2 Alteogen 10.17
3 Celltrion 10.00
4 HLB 7.32
5 Yuhan 5.34
6 ABL Bio 5.29
7 SCD 4.52
8 LCB 4.39
9 SKBP 4.38
10 SAMSUNG EPIS HOLDINGS 3.67

proportion by sectors

*The proportion of investment stocks

Update : 2026.06.19
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2026-04-30 2026-05-06 25
2025-04-30 2025-05-07 20
2023-04-28 2023-05-03 16
2022-04-29 2022-05-03 60

Performance

performance

excel download

Update : 2026-06-19

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)		 Since
inception
NAV -6.75 -24.06 -18.67 -1.88 21.49 -18.65 35.05
Benchmark Index -6.93 -24.57 -19.18 -2.12 21.18 -19.05 35.50
Outperformance 0.17 0.51 0.5 0.24 0.3 0.4 -0.46

daily Performance

excel download

-
search
date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW) Standard Tax Base Price (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2026.06.19 13,705 -2.939하락 13,677.15 -2.949하락 10,357.09
2026.06.18 14,120 -2.351하락 14,092.78 -2.198하락 10,357.14
2026.06.17 14,460 3.804상승 14,409.55 3.630상승 10,357.18
2026.06.16 13,930 1.419상승 13,904.7 0.786상승 10,357.23
2026.06.15 13,735 0.992상승 13,796.18 1.862상승 10,357.27
2026.06.12 13,600 1.040상승 13,544.02 -0.437하락 10,357.39
2026.06.11 13,460 1.546상승 13,603.47 2.052상승 10,357.43
2026.06.10 13,255 -1.266하락 13,329.88 -0.863하락 10,357.47
2026.06.09 13,425 5.088상승 13,445.97 5.404상승 10,357.51
2026.06.08 12,775 -8.750하락 12,756.56 -9.038하락 10,357.54
2026.06.05 14,000 -3.514하락 14,024.19 -2.932하락 10,357.66
2026.06.04 14,510 -0.034하락 14,447.85 -0.463하락 10,357.7
2026.06.02 14,515 -2.942하락 14,515.19 -2.700하락 10,357.77
2026.06.01 14,955 0.369상승 14,917.98 -0.052하락 10,357.81
2026.05.29 14,900 -0.234하락 14,925.87 -0.430하락 10,357.93
2026.05.28 14,935 -2.544하락 14,990.38 -2.710하락 10,357.97
2026.05.27 15,325 -0.162하락 15,408.05 0.219상승 10,358.01
2026.05.26 15,350 -0.807하락 15,374.24 -0.353하락 10,358.05
2026.05.22 15,475 5.379상승 15,428.9 5.535상승 10,358.22
2026.05.21 14,685 3.597상승 14,619.59 2.697상승 10,358.26

Holdings

search
Download holdings data
Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 SAMSUNG BIOLOGICS KR7207940008 52 10.55 74,360,000
2 Alteogen KR7196170005 194 10.17 71,683,000
3 Celltrion KR7068270008 406 10 70,481,600
4 HLB KR7028300002 1,030 7.32 51,603,000
5 Yuhan KR7000100008 481 5.34 37,614,200
6 ABL Bio KR7298380007 368 5.29 37,278,400
7 SCD KR7000250001 121 4.52 31,823,000
8 LCB KR7141080002 230 4.39 30,935,000
9 SKBP KR7326030004 348 4.38 30,867,600
10 SAMSUNG EPIS HOLDINGS KR70126Z0002 57 3.67 25,849,500
11 HanmiPharm KR7128940004 55 3.32 23,402,500
12 PharmaResearch KR7214450009 58 2.45 17,284,000
13 HANALL BIOPHARMA KR7009420001 306 2.38 16,799,400
14 ST Pharm KR7237690003 113 2.04 14,351,000
15 L&C BIO KR7290650001 158 1.8 12,671,600
16 Hugel KR7145020004 46 1.64 11,546,000
17 CLASSYS KR7214150005 232 1.51 10,660,400
18 ORUM KR7475830006 161 1.46 10,320,100
19 SKBS KR7302440003 230 1.29 9,062,000
20 Lunit KR7328130000 608 1.17 8,274,880
21 SEEGENE KR7096530001 278 1.14 8,006,400
22 원화예금 KRD010010001 7,900,404 1.12 7,900,404
23 Celltrionph KR7068760008 178 1.09 7,707,400
24 Pharmicell KR7005690003 485 0.98 6,911,250
25 GC Biopharma Corp. KR7006280002 48 0.89 6,268,800
26 CHA Biotech KR7085660009 520 0.89 6,281,600
27 Hanmi Science KR7008930000 176 0.75 5,297,600
28 HK inno.N KR7195940002 123 0.72 5,086,050
29 CHONGKUNDANG KR7185750007 69 0.7 4,905,900
30 DAEWOONG PHARM KR7069620003 39 0.67 4,722,900
31 MedyTox KR7086900008 47 0.58 4,107,800
32 DongKook Pharm KR7086450004 205 0.55 3,856,050
33 ILDONG PHARM KR7249420001 183 0.49 3,480,660
34 KLS KR7102940004 65 0.45 3,185,000
35 JWPHARMA KR7001060003 116 0.45 3,161,000
36 ShinpoongPharm KR7019170000 345 0.44 3,080,850
37 HLBPHARMA KR7047920004 242 0.44 3,129,060
38 i-SENS KR7099190001 189 0.43 3,054,240
39 EuBio KR7206650004 271 0.37 2,585,340
40 CUREXO KR7060280005 253 0.37 2,605,900
41 DENTIUM KR7145720009 57 0.36 2,539,350
42 WONTECH KR7336570007 374 0.33 2,311,320
43 T&L KR7340570001 40 0.32 2,244,000
44 GC Corp. KR7005250006 188 0.3 2,115,000
45 Binex KR7053030003 250 0.28 1,982,500
46 Huons Global KR7084110006 47 0.18 1,245,500
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.